Mimedx (MDXG) Shares Outstanding (Weighted Average) (2010 - 2026)

Mimedx has disclosed Shares Outstanding (Weighted Average) across 17 years of filings, most recently posting $148.4 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $148.4 million, up 0.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $148.4 million (up 0.8% YoY), and the FY2025 annual result was $147.8 million, up 0.55% from the prior year.
• Shares Outstanding (Weighted Average) came in at $148.4 million for Q1 2026 at Mimedx, roughly flat from $147.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $148.4 million in Q1 2026 to a low of $111.6 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $146.4 million (2024), against an average of $131.8 million.
• Across the five-year window, Shares Outstanding (Weighted Average) rose 27.98% in 2024 and gained 0.3% in 2025, its largest moves.
• Mimedx's Shares Outstanding (Weighted Average) stood at $112.9 million in 2022, then climbed by 3.18% to $116.5 million in 2023, then grew by 26.17% to $147.0 million in 2024, then grew by 0.55% to $147.8 million in 2025, then rose by 0.44% to $148.4 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $148.4 million (Q1 2026), $147.8 million (Q4 2025), and $148.0 million (Q3 2025), per Business Quant data.